| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |